EY Recommends Focusing On Fundamentals, Waiting For Prime Deal Conditions

 
• By Joseph Haas
Person jumping over a hole, depicting financial volatility
Volatility in finance and policy outcomes creates a good time for pharma to focus on fundamentals, says EY (Shutterstock)

More from Deals

More from Strategy